Kristen McEachern, PhD
Vice President, Research & Translational Medicine
Kristen joined Clasp in February 2024. She most recently was Vice President of Translational Sciences at Ribon Therapeutics where she provided scientific and translational leadership for programs from Discovery through Phase 2. Kristen brings more than 15 years of experience in Discovery and Translational Medicine in oncology, immune-oncology and inflammation, bringing novel small and large molecule therapies, including several first-in-class medicines, into the clinic. Earlier in her career, Kristen worked to develop molecular diagnostic assays at EXACT Sciences. She holds a PhD in Molecular and Cellular Biology from Dartmouth Medical School and a BA in Chemistry/Biochemistry from Regis College.